Comparison of serum lactate and lactate-derived ratios as prognostic biomarkers in pediatric dengue shock syndrome using supervised machine learning models
PLOS One · 2025
DOI: 10.1371/journal.pone.0335022 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift PLOS One, 2025. Verfasst von Nguyen Tat Thanh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Children Hospital 2, Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: Severe Dengue, Lactic Acid, Supervised Machine Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Dengue shock syndrome (DSS), with critical complications encompassing mechanical ventilation (MV), dengue-associated acute liver failure (PALF), and encephalitis, is associated with high mortality in children. Although serum lactate is a recognized prognostic biomarker, it may not fully reflect the complex metabolic disturbances in DSS. Recent evidence suggests that lactate-derived indices, including lactate-to-albumin ratio (LAR) and lactate-to-bicarbonate ratio (LB), may enhance prognostic accuracy. This study aimed to evaluate and compare the predictive performance of the LAR, LB ratio, and serum lactate levels in pediatric DSS using machine learning approaches. Methods and findings We conducted a secondary analysis of a retrospective cohort study involving children with DSS at a tertiary pediatric center in Vietnam (2013–2022). The primary composite endpoint included in-hospital mortality, MV, dengue-associated PALF and encephalitis. Predictors were selected based on clinical expertise, literature review, Akaike Information Criterion and Least Absolute Shrinkage and Selection Operator. Multiple supervised machine-learning algorithms – logistic regression, random forest (RF), support vector machine (SVM), k-nearest neighbor, naïve Bayes, AdaBoost, and XGBoost - were applied. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and feature importance was assessed using Shapley Additive Explanations (SHAP).
Results
Of the 524 eligible patients (median age: 8.7 years), 17% met the composite endpoint. At admission, LAR demonstrated superior discriminatory ability (AUC: 0.82; 95% CI: 0.76–0.87) compared to serum lactate (AUC: 0.72; 95% CI: 0.65–0.78) and LB ratio (AUC: 0.68; 95% CI: 0.62–0.74) (all p < 0.001). The Youden-index based optimal LAR cutoff was 1.25, whereas that for the LB ratio was 0.20. The RF, XGBoost and SVM models achieved the highest performance. SHAP analysis revealed that LAR was the most influential predictor among the lactate-based variables.
Conclusions
LAR exceeded serum lactate and the LB ratio in predicting critical outcomes in pediatric DSS. These findings support its utility as a practical and accessible tool for early risk stratification in DSS patients. These results support the use of LAR as a practical and accessible tool for risk stratification in pediatric dengue care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Children Hospital 2, Ho Chi Minh City, Vietnam.
- TB Department, Woolcock Institute of Medical Research, Ho Chi Minh City, Vietnam.
ORCID-Profile: Nguyen Tat Thanh
Zitieren
APA
Thanh, N. T., & Luan, V. T. (2025). Comparison of serum lactate and lactate-derived ratios as prognostic biomarkers in pediatric dengue shock syndrome using supervised machine learning models. PLOS One. https://doi.org/10.1371/journal.pone.0335022
Vancouver
Thanh NT, Luan VT. Comparison of serum lactate and lactate-derived ratios as prognostic biomarkers in pediatric dengue shock syndrome using supervised machine learning models. PLOS One. 2025. doi:10.1371/journal.pone.0335022
BibTeX
@article{Thanh2025,
author = {Thanh, Nguyen Tat and Luan, Vo Thanh},
title = {Comparison of serum lactate and lactate-derived ratios as prognostic biomarkers in pediatric dengue shock syndrome using supervised machine learning models},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0335022}
}
EUVIMED